Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Johnson and Johnson
McKesson
Boehringer Ingelheim
Cantor Fitzgerald
Farmers Insurance
Merck
McKinsey

Generated: April 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dalfampridine

« Back to Dashboard

dalfampridine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Acorda AMPYRA dalfampridine TABLET, EXTENDED RELEASE;ORAL 022250 NDA Acorda Therapeutics, Inc. N 10144-427-60
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Deloitte
Merck
UBS
Dow
Argus Health
Moodys
Fish and Richardson